Divis Laboratories Ltd reported INR3.4B in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.





Selling And Administration Expenses Change Date
Alaunos Therapeutics USD 424K 23K Jun/2026
Aurobindo Pharma INR 12.77B 485.3M Sep/2025
Avita Medical AUD 19.54M 516K Jun/2026
Dianthus Therapeutics USD 13.56M 1.09M Jun/2026
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Ionis Pharmaceuticals USD 154M 23.92M Sep/2026
IQVIA Holdings USD 569M 5M Sep/2026
Lupin INR 11.06B 225.6M Sep/2025
Moderna USD 282M 66M Sep/2026
Organon & Co USD 407M 27M Sep/2026
Revvity USD 275.33M 3.25M Sep/2026
Tectonic Therapeutic USD 6.17M 260K Jun/2026
Tilray USD 24.85M 1.7M Sep/2025
Viatris USD 950.8M 183.7M Sep/2026
Xeris Pharmaceuticals USD 61.04M 7.89M Jun/2026